Navigation Links
BioStorage Technologies Appoints New Member to Board of Directors
Date:12/8/2011

INDIANAPOLIS, Dec. 8, 2011 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions including consulting, storage, cold chain logistics and virtual sample intelligence and tracking for the bioscience industry, announced today that Thomas J. Newman, M.D., has been appointed to the company's board of directors. Dr. Newman joins BioStorage Technologies with more than 30 years of executive and leadership experience in the contract services and pharmaceutical industries.

"We are pleased to have an industry expert of Dr. Newman's caliber as a member of our board and are certain that he will provide significant contributions to the shared vision for BioStorage Technologies' growth and market expansion next year and beyond," said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. "His vast amount of experience in contract services will only add to our boards' already extensive knowledge of the pharmaceutical industry."

Most recently, Dr. Newman served as President of PharmaNet Development Group, a global drug development services company, where he was responsible for worldwide operations. He also served in various capacities of executive leadership at Covance and Bristol-Myers Squibb. Prior to joining industry he was on the faculty of the Department of Pediatrics at the University of Minnesota Medical School.

Dr. Newman received his M.D. from Tufts University School of Medicine and his Bachelor of Arts degree in biology from Cornell University.

About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
2. BioStorage Technologies Expands Liquid Nitrogen Storage in Germany-based Biorepository Facility
3. BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
4. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
5. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
8. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
9. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
10. BioStorage Technologies Appoints New Vice President of Global Sales
11. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS Bioanalytical and Biomarker Services, ... Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui has more than 15 ... for preclinical and clinical safety programs. “We’ve seen significant demand for, and we ...
(Date:5/18/2016)... 2016 The Biotech industry continues to ... that there are no opportunities ahead. Today, ActiveWallSt.com has on ... THLD ), Seattle Genetics Inc. (NASDAQ: SGEN ... Corp. (NASDAQ: OPHT ). Sign up now to ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares gained ...
(Date:5/17/2016)... -- Haselmeier announces the launch by Merck ... EMA, the European Medicines Agency. Originally launched in 2011 ... new pen version includes enhancements to further improve the ... patients during use. Its enhanced design has ... with a larger display window that improves the readability ...
(Date:5/17/2016)... BASEL, Switzerland , May 17, 2016 /PRNewswire/ ... sciences company located in Basel, Switzerland ... an investigational oral inhibitor of P38 mitogen-activated protein ... ) , Strekin will build the ... Pamapimod in indications in which MAP Kinases play ...
Breaking Biology Technology:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):